James Field

What if machines could engineer life?

Share This Talk

Have a suggestion for The Hive?
Submit a Nomination Today

About James Field

James is founder and CEO of LabGenius, a synthetic biology company that harnesses AI & multiplexed gene synthesis to evolve novel materials. James completed his PhD studies at Imperial College London where his research was focused on re-engineering protein nanocages for biotechnological applications. Prior to his PhD, James completed a BSc in Biology with Microbiology and an MRes in Systems and Synthetic Biology, at Imperial College London. James is an active member of the synthetic biology community having participated in the iGEM competition both as an undergraduate (2009), advisor (2011) and judge (2016). In 2017, James was awarded the BBSRC Innovator of the Year award for early career impact. James is also a fellow of the prestigious Synthetic Biology Leadership Excellence Accelerator Program (LEAP).

Find out more

About This Idea

James Field is the CEO of LabGenius, a UK company paving the way for new biological advancements, therapies, and discoveries. Instead of focusing on research performed by people, LabGenius built EVA—the company’s artificial intelligence-driven evolution engine—to unlock a new wave of bio-augmented materials using AI and a library of synthetic DNA. Tune into James's 2017 TEDMED Hive Talk to learn how LabGenius is enabling us to use advanced technologies to break through cognitive barriers and redefining our relationship to artificial intelligence.

Find out more

More Talks from the Hive

These talks are all a part of special session at TEDMED, called "Audacious" where we invite our innovators to take the stage and share the central idea they are working on, in short 2-minute talks. These talks are creatively grouped by 4 mini-segments, that serves as a creative link between each talk. To find out more visit The Hive page.